Investors Try Life in the Slow Lane with Healthcare Stocks…..Update-4 SMID Biotech Rally Fading Already?
3/1/24...Still plenty of good biotech trades around as XBI recovers over 3% to $101.53. Big movers today were: ABOS, CRMD, DNLI, GERN, IMTX, SUPN. https://www.nasdaq.com/market-activity/etf/xbi/advanced-charting 2/29 at close ..MOmentum is easing with volatility making trading more difficult...
Healthcare Stocks Are Looking Better But What About Biotech ?…Update-1
Update-1 2/23/24. You know the story by now it's all about AI and NVDA. As my friend said in the mid -90s "there is no end to chips Rod". Overall one of the best weeks for the market but of course led by technology stocks. The equal weight small cap XBI hit a new 1 yr high at the $95 level but...
Large Cap Biopharmaceuticals: Performance Metrics..Update-1
Update-1..2/15/24...Post from 9/23 biotech bottom when we picked ABBV,GEHC. Near/at new 52 wk. highs : ABBV, LLY, MRK, VRTX, XPH etc. Update- -2/12/24....Gilead Sciences responds immediately to recent trial disappointment to buy CymaBay,a $4.3B deal expanding liver portfolio. See chart below...
Healthcare and Life Science Funds and ETFs Performance 2023-2024
Healthcare and Life Science Funds and ETFs Healthcare stocks usually provide a defensive posture to a stock portfolio. SMID biotech stocks have been in a bear market since late 2021 but they are coming back since late 2023. So the weighting of large cap biophharma determined its performance....
Biotech and MedTech Portfolio Notes on a FED Day…Update 4… 2/15 Small cap rally continues
Update-4. 2/15....2:30p EST XBI pushing for new 52 weeks highs at $93.61. Biotechs/medtechs strong: CRBU, CRMD, CRSP, CPRX, CYRX, ILMN,SUPN, TWST, VCEL. Update-3 2/6..3P EST Some of my SMID caps are coming alive as the XBI ticks up to $89 level: strength among my holdings: CRSP,CYRX, GEHC,...